The Xbp1s/GalE axis links ER stress to postprandial hepatic metabolism

Journal of Clinical Investigation

Volumn 123, Issue 1, 2013, Pages 455-468

  Deng, Yingfeng ^a   Wang, Zhao V ^a   Tao, Caroline ^a   Gao, Ningguo ^a   Holland, William L ^a   Ferdous, Anwarul ^a   Repa, Joyce J ^a   Liang, Guosheng ^a   Ye, Jin ^a   Lehrman, Mark A ^a   Hill, Joseph A ^a   Horton, Jay D ^a   Scherer, Philipp E ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 6; CHAPERONE; GLUCOSE; GLYCOGEN; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; INITIATION FACTOR 2; INSULIN; MESSENGER RNA; PROTEIN IRE1; TUNICAMYCIN; URIDINE DIPHOSPHATE GLUCOSE 4 EPIMERASE; X BOX BINDING PROTEIN 1;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CALORIC INTAKE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM STRESS; GENE OVEREXPRESSION; GENE TARGETING; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GLYCOGEN LIVER LEVEL; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN SENSITIVITY; LIPID STORAGE; LIPOLYSIS; LIVER METABOLISM; LIVER WEIGHT; METABOLIC DISORDER; MOUSE; NONHUMAN; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INDUCTION; REFEEDING; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TRANSIENT EXPRESSION; UNFOLDED PROTEIN RESPONSE; UPREGULATION;

ANIMALS; CELLS, CULTURED; DNA-BINDING PROTEINS; ENDOPLASMIC RETICULUM-ASSOCIATED DEGRADATION; HEPATOCYTES; LIVER; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; POSTPRANDIAL PERIOD; PROTEIN-SERINE-THREONINE KINASES; RABBITS; TRANSCRIPTION FACTORS; UDPGLUCOSE 4-EPIMERASE;

EID: 84873873215     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI62819     Document Type: Article

References (43)

1. Pfaffenbach KT, et al. Rapamycin inhibits postprandial- mediated X-box-binding protein-1 splicing in rat liver. J Nutr. 2010;140(5): 879-884.
2. Schroder M, Kaufman RJ. The mammalian unfolded protein response. Annu Rev Biochem. 2005; 74: 739-789.
3. Walter P, Ron D. The unfolded protein response: from stress pathway to homeostatic regulation. Science. 2011;334(6059): 1081-1086.
4. Winnay JN, Boucher J, Mori MA, Ueki K, Kahn CR. A regulatory subunit of phosphoinositide 3-kinase increases the nuclear accumulation of X-box-binding protein-1 to modulate the unfolded protein response. Nat Med. 2010;16(4): 438-445.
5. Park SW, et al. The regulatory subunits of PI3K, p85alpha and p85beta, interact with XBP-1 and increase its nuclear translocation. Nat Med. 2010; 16(4): 429-437.
6. Zhou Y, et al. Regulation of glucose homeostasis through a XBP-1-FoxO1 interaction. Nat Med. 2011; 17(3): 356-365.
7. Ozcan U, et al. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science. 2004;306(5695): 457-461.
8. Lee AH, Scapa EF, Cohen DE, Glimcher LH. Regulation of hepatic lipogenesis by the transcription factor XBP1. Science. 2008;320(5882): 1492-1496.
9. Leloir LF. The enzymatic transformation of uridine diphosphate glucose into a galactose derivative. Arch Biochem Biophys. 1951;33(2): 186-190.
10. Hellerstein MK, Munro HN. Glycoconjugates as noninvasive probes of intrahepatic metabolism: III. Application to galactose assimilation by the intact rat. Metabolism. 1988;37(4): 312-317.
11. Belteki G, et al. Conditional and inducible transgene expression in mice through the combinatorial use of Cre-mediated recombination and tetracycline induction. Nucleic Acids Res. 2005;33(5):e51.
12. Lee AH, Iwakoshi NN, Glimcher LH. XBP-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded protein response. Mol Cell Biol. 2003;23(21): 7448-7459.
13. Yoshida H, Matsui T, Yamamoto A, Okada T, Mori K. XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell. 2001;107(7): 881-891.
14. Rutkowski DT, et al. UPR pathways combine to prevent hepatic steatosis caused by ER stress-mediated suppression of transcriptional master regulators. Dev Cell. 2008;15(6): 829-840.
15. Knopp RH. Drug treatment of lipid disorders. N Engl J Med. 1999;341(7): 498-511.
16. Chou JY, Jun HS, Mansfield BC. Glycogen storage disease type I and G6Pase-beta deficiency: etiology and therapy. Nat Rev Endocrinol. 2010;6(12): 676-688.
17. Fang M, et al. The ER UDPase ENTPD5 promotes protein N-glycosylation, the Warburg effect, and proliferation in the PTEN pathway. Cell. 2010; 143(5): 711-724.
18. Yamamoto K, Yoshida H, Kokame K, Kaufman RJ, Mori K. Differential contributions of ATF6 and XBP1 to the activation of endoplasmic reticulum stress-responsive cis-acting elements ERSE, UPRE and ERSE-II. J Biochem. 2004;136(3): 343-350.
19. Kingsley DM, Krieger M, Holton JB. Structure and function of low-density-lipoprotein receptors in epimerase-deficient galactosemia. N Engl J Med. 1986;314(19): 1257-1258.
20. Sriburi R, et al. Coordinate regulation of phospholipid biosynthesis and secretory pathway gene expression in XBP-1(S)-induced endoplasmic reticulum biogenesis. J Biol Chem. 2007;282(10): 7024-7034.
21. Jin F, Kretschmer PJ, Harkins RN, Hermiston TW. Enhanced protein production using HBV X protein (HBx), and synergy when used in combination with XBP1s in BHK21 cells. Biotechnol Bioeng. 2009; 105(2): 341-349.
22. Frey PA. The Leloir pathway: a mechanistic imperative for three enzymes to change the stereochemical configuration of a single carbon in galactose. FASEB J. 1996;10(4): 461-470.
23. Novelli G, Reichardt JK. Molecular basis of disorders of human galactose metabolism: past, present, and future. Mol Genet Metab. 2000;71(1-2): 62-65.
24. Bosch AM. Classical galactosaemia revisited. J Inherit Metab Dis. 2006;29(4): 516-525.
25. Walter JH, et al. Generalised uridine diphosphate galactose-4-epimerase deficiency. Arch Dis Child. 1999;80(4): 374-376.
26. Sanders RD, Sefton JM, Moberg KH, Fridovich-Keil JL. UDP-galactose 4' epimerase (GALE) is essential for development of Drosophila melanogaster. Dis Model Mech. 2010;3(9-10): 628-638.
27. Timson DJ. The structural and molecular biology of type III galactosemia. IUBMB Life. 2006;58(2): 83-89.
28. Liu Y, et al. XBP1S associates with RUNX2 and regulates chondrocyte hypertrophy. J Biol Chem. 2012;287(41): 34500-34513.
29. Lee AS. The glucose-regulated proteins: stress induction and clinical applications. Trends Biochem Sci. 2001;26(8): 504-510.
30. Csala M, Margittai E, Banhegyi G. Redox control of endoplasmic reticulum function. Antioxid Redox Signal. 2010;13(1): 77-108.
31. Wouters BG, Koritzinsky M. Hypoxia signalling through mTOR and the unfolded protein response in cancer. Nat Rev Cancer. 2008;8(11): 851-864.
32. Romero-Ramirez L, et al. XBP1 is essential for survival under hypoxic conditions and is required for tumor growth. Cancer Res. 2004;64(17): 5943-5947.
33. Uhlen M, et al. Towards a knowledge-based Human Protein Atlas. Nat Biotechnol. 2010;28(12): 1248-1250.
34. Shimano H, Horton JD, Hammer RE, Shimomura I, Brown MS, Goldstein JL. Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a. J Clin Invest. 1996;98(7): 1575-1584.
35. Laplante M, et al. Tissue-specific postprandial clearance is the major determinant of PPARgammainduced triglyceride lowering in the rat. Am J Physiol Regul Integr Comp Physiol. 2009;296(1):R57-R66.
36. Asterholm IW, Scherer PE. Enhanced metabolic flexibility associated with elevated adiponectin levels. Am J Pathol. 2010;176(3): 1364-1376.
37. Sunny NE, et al. Progressive adaptation of hepatic ketogenesis in mice fed a high-fat diet. Am J Physiol Endocrinol Metab. 2010;298(6):E1226-E1235.
38. Gao N, Lehrman MA. Non-radioactive analysis of lipid-linked oligosaccharide compositions by fluorophore- assisted carbohydrate electrophoresis. Methods Enzymol. 2006;415: 3-20.
39. Huang Y, Mechref Y, Novotny MV. Microscale nonreductive release of O-linked glycans for subsequent analysis through MALDI mass spectrometry and capillary electrophoresis. Anal Chem. 2001; 73(24): 6063-6069.
40. Lagace TA, et al. Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and in livers of parabiotic mice. J Clin Invest. 2006;116(11): 2995-3005.
41. Ferdous A, Sikder D, Gillette T, Nalley K, Kodadek T, Johnston SA. The role of the proteasomal ATPases and activator monoubiquitylation in regulating Gal4 binding to promoters. Genes Dev. 2007;21(1): 112-123.
42. Li S, Brown MS, Goldstein JL. Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis. Proc Natl Acad Sci U S A. 2010; 107(8): 3441-3446.
43. Iwakoshi NN, Lee AH, Vallabhajosyula P, Otipoby KL, Rajewsky K, Glimcher LH. Plasma cell differentiation and the unfolded protein response intersect at the transcription factor XBP-1. Nat Immunol. 2003;4(4): 321-329.